Filing Details

Accession Number:
0001181431-10-024530
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-05 13:00:00
Reporting Period:
2010-05-03
Filing Date:
2010-05-05
Accepted Time:
2010-05-05 15:56:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385830 Neurogesx Inc NGSX Pharmaceutical Preparations (2834) 943307935
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1367381 Sv Life Sciences Fund Iv Lp 60 State Street, Suite 3650
Boston MA 02109
No No Yes No
1392309 P L Partners Strategic Iv Fund Sciences Life Sv 60 State Street, Suite 3650
Boston MA 02109
No No Yes No
1422339 Svlsf Iv, Llc 60 State Street, Suite 3650
Boston MA 02109
No No Yes No
1422340 Sv Life Sciences Fund Iv (Gp), L.p. 60 State Street, Suite 3650
Boston MA 02109
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-05-03 291,718 $10.25 2,159,991 No 4 S Direct
Common Stock Disposition 2010-05-03 8,282 $10.25 61,324 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. These shares were sold by SV Life Sciences Fund IV, L.P. ("SVLS IV LP"). SV Life Sciences Fund IV (GP), L.P. ("SVLS IV GP"), the general partner of SVLS IV LP, may be deemed to have voting and dispositive power over the securities held by SVLS IV LP. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to have voting and dispositive power over the securities held by SVLS IV LP. Each of SVLS IV GP and SVLSF IV, LLC disclaims beneficial ownership of securities held by SVLS IV LP except to the extent of any pecuniary interest therein. SVLS IV LP and SV Life Sciences Fund IV Strategic Partners, L.P. ("Strategic Partners") (each a "Fund", or collectively the "Funds") may be deemed to beneficially own the securities held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of securities held by any other Fund except to the extent of any pecuniary interest therein.
  2. These shares were sold by Strategic Partners. SVLS IV GP, the general partner of Strategic Partners, may be deemed to have voting and dispositive power over the securities held by Strategic Partners. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to have voting and dispositive power over the securities held by Strategic Partners. Each of SVLS IV GP and SVLSF IV, LLC disclaims beneficial ownership of securities held by Strategic Partners except to the extent of any pecuniary interest therein. Each Fund may be deemed to beneficially own the securities held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of securities held by any other Fund except to the extent of any pecuniary interest therein.